On the stock market since 2025, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
No real growth (4% a year). Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades below its recent peak — about 10% off the top. A pullback, not a collapse.
Over the last 3 years, sales grew about 12% a year on average.
Sales run at $387.1M a year. A small number, but proof the product has real buyers.
It pays out $0.17 per share each year — regular cash for whoever holds the stock.
A loss of $9.6M against $387.1M in annual sales. And on top of that, sales fell from the year before.
The price action doesn’t yet back an upward turn.
On our five-subject report card, GRIN sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: GRIN is a high-risk stock — not yet profitable, and its future rides on its product catching on.